1. Home
  2. SHO vs VIR Comparison

SHO vs VIR Comparison

Compare SHO & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

HOLD

Current Price

$10.80

Market Cap

1.8B

ML Signal

HOLD

Logo Vir Biotechnology Inc.

VIR

Vir Biotechnology Inc.

N/A

Current Price

$8.96

Market Cap

1.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SHO
VIR
Founded
1995
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
2004
2019

Fundamental Metrics

Financial Performance
Metric
SHO
VIR
Price
$10.80
$8.96
Analyst Decision
Hold
Strong Buy
Analyst Count
7
7
Target Price
$9.79
$19.43
AVG Volume (30 Days)
2.5M
1.5M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
3.66%
N/A
EPS Growth
N/A
17.49
EPS
0.22
N/A
Revenue
$1,115,167,000.00
$68,556,000.00
Revenue This Year
$3.95
$270.22
Revenue Next Year
$2.30
N/A
P/E Ratio
$48.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.69
$4.25
52 Week High
$12.07
$11.66

Technical Indicators

Market Signals
Indicator
SHO
VIR
Relative Strength Index (RSI) 32.94 47.39
Support Level $8.82 $8.43
Resistance Level $12.01 $10.10
Average True Range (ATR) 0.27 0.41
MACD -0.13 0.01
Stochastic Oscillator 12.69 41.14

Price Performance

Historical Comparison
SHO
VIR

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.

Share on Social Networks: